Miscellaneous products

Pyridoxine impurity A :

6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol ; C8H9NO2;  MW: 151.16  g/mol ;

CAFFEINE MELTING POINT STANDARD :

3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; C₈H₁₀N₄O₂ ;  MW: 194.19  g/mol ;

Nicotinic Acid :

Niacin, 3-Pyridinecarboxylic acid; C₆H₅NO₂ ;  MW: 123.11  g/mol ;

(R)-2-hydroxy-2-phenyl-acetic acid anhydride :

C16H14O5 ;  MW: 286.28  g/mol ;

Ethyl 4-aminobenzoate-Starting material :

4-Aminobenzoic Acid Ethyl Ester; p-Aminobenzoic Acid Ethyl Ester ; C₉H₁₁NO₂ ;  MW: 165.19 g/mol ;

Ethyl (4-N-butylamino)benzoate In process impurities :

4-(Butylamino)benzoic Acid Ethyl Ester ; C13H19NO2 ;  MW: 221.30    g/mol ;

Dimethylamine – Starting material :

N-Methylmethanamine ; C2H7N ;  MW: 45.08    g/mol ;

Butyl4-N-butylaminobenzoate  In process impurities :

butyl 4-(butylamino)benzoate ; C15H23NO2 ;  MW: 249.35    g/mol ;

DIAZEPAM IMPURITY B :

2-CHLORO-N-(4-CHLORO-2-BENZOYLPHENYL)-N-METHYLACETAMIDE ; C16H13Cl2NO2 ;  MW: 322.19 g/mol;

2-N,NDimethylaminoethyl 4- aminobenzoate In process impurities :

2-(dimethylamino)ethyl 4-aminobenzoate; C11H16N2O2  ;  MW: 208.26  g/mol ;

2-(N,N-Dimethylamino)ethanol In process impurities :

2-(N,N-Dimethylamino)ethanol ; C4H11NO ;  MW: 89.14   g/mol ;

Naproxen impurity :

2-(6-Methoxy-2-naphthyl)propionic Acid; C₁₄H₁₄O₃ ;  MW: 230.26  g/mol ;

3-hydroxy acetophenone :

C₈H₈O₂ ;  MW: 136.15  g/mol ;

2-NAPHTHALENE ACETIC ACID :

C₁₂H₁₀O₂ ;  MW: 186.21  g/mol ;

Vaniline standard :

4-Hydroxy-3-methoxybenzaldehyde; C₈H₈O₃ ;  MW: 152.15 g/mol ;

methyl 2-chloro-2-(2-chlorophenyl)acetate:

C9H8Cl2O2 ;  MW:219.06 g/mol ;

p-Carboxyphenol :

p-Carboxyphenol; C₇H₆O₃ ;  MW:138.12 g/mol ;

5- cytidine monophosphate :

5- cytidine monophosphate ; C₉H₁₄N₃O₈P  ;  MW: 323.20 g/mol ;

Cyanocobalamin  chemical reference standard  :

5,6-Dimethylbenzimidazolyl Cyanocobamide  ;

CAS No.: 68-19-9 ; C₆₃H₈₈CoN₁₄O₁₄P  ;  MW:1355.37 g/mol ;

Atropic Acid :

α-Methylenebenzeneacetic Acid  ;

C9H8O2 ;  MW:148.16 g/mol  ;

Isopropyl para toluene sulfonate :

4-Methylbenzenesulfonic Acid 1-Methylethyl Ester ;

CAS No.:2307-69-9 ; C₁₀H₁₄O₃S ;  MW: 214.28 g/mol ;

Fluoro dinitrobenzene :

4-Fluoro-1,3-dinitrobenzene ; C₆H₃FN₂O₄ ;  MW: 186.1 g/mol ;

GUANINE :

2-Amino-1,9-dihydro-6H-purin-6-one ; CAS No.:73-40-5 ;  C5H5N5O ;  MW: 151.13 g/mol ;

Piperidine Impurity  :

Hexahydropyridine ; C₅H₁₁N ; MW: 85.15 g/mol ;

Ethyl (2R)-2-(6-methoxynaphthalen-2-yl)propanoate :

C16H18O3 ; MW: 258.31 g/mol ;

Methyl (2R)-2-(6-methoxynaphthalen-2-yl)propanoate :

C15H16O3 ; MW: 244.29 g/mol ;

sodium morpholine-4-carbodithioate :

C5H8NNaOS2 ; MW: 185.24 g/mol ( 163.26 g/mol  free acid ) ;

HAYOCIN HYDRO BROMIDE  TRIHYDRATE :

[7(S)-(1α,2β,4β,5α,7β)]-α-(Hydroxymethyl)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester Benzeneacetic Acid Hydrobromide Trihydrate ; C₁₇H₂₁NO₄ • HBr • ₃(H ₂O)  ; MW: 384.27 g/mol ( 303.3 g/mol );

1-phenyl-2-(pyridin-2-ylamino)ethanol hydrochloride :

C13H15ClN2O ; MW: 250.72 g/mol ( 214.26 g/mol + 36.5 g/mol) ;

N,O- fluorophenyl butyryl haloperidol :

4-[4-(4-chlorophenyl)-4-(4-(4-fluorophenyl)-4-oxobutoxy)piperidin-1-yl]-1-(4-fluorophenyl)-butan-1-one; C31H32ClF2NO3 ; MW: 540.04 g/mol ;

N,C- fluorophenyl butyryl haloperidol :

2-(2-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)ethyl)-1,6-bis(4-fluorophenyl)hexane-1,6-dione; C31H32ClF2NO3 ; MW: 540.04 g/mol ;

Azilsartan Hydrochloride chemical reference standards :

1-[[2’-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1’-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic Acid; CAS. no: 863031-21-4 ; C₂₅H₂₀N₄O₅ ; MW: 456.46 g/mol ;

Mercaptopurine disulphide impurity :

6,6’-Dithiodi-9H-purine; 6,6’-Dithiobis- 1H-purine; 6,6’-Dithiodi-purine; C₁₀H₆N₈S₂ ; MW: 302.34 g/mol  ;

Pemetrexed Disodium CRS :

N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Hydrate; CAS No: 357166-29-1 ;C20H21N5O6 ; MW:427.4 g/mol ( 425.42 g/mol + 46.0 g/mol ) ;

4-Bromomethyl-2’-Cyanobiphenyl impurity 1 :

2-Cyano-4′-bromomethylbiphenyl ; C14H10BrN; MW: 272.14 g/mol ;

 MEQUINOL IMPURITY :

p-Methoxyphenol; CAS No:150-76-5 ; C₇H₈O₂  ; MW: 124.14 g/mol ;

Melatonin impurity :

N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide; 5-Methoxy-N-acetyltryptamine ;  C₁₃H₁₆N₂O₂ ; MW: 232.28 g/mol ;

DIBENZOYL-L-TARTARIC ACID :

(2R,3R)-2,3-Bis(benzoyloxy)butanedioic Acid ; CAS No: 2743-38-6 ; C₁₈H₁₄O₈ ; MW: 358.30  g/mol ;

BIS(2-AMINOPHENYL) SULFONE:

CAS No: 53347-49-2;C₁₂H₁₂N₂O₂S; MW: 248.3  g/mol ;

Diclofenac Diethylamine Salt:

2-[(2,6-Dichlorophenyl)amino]benzeneacetate N-Ethylethanamine; CAS No: 78213-16-8; C₁₈H₂₂Cl₂N₂O₂ ; MW: 369.29  g/mol ;

Simvastatin Impurity D :

Simvastatin Dimer Impurity ; (3R,5R)-((2R,4R)-2-(2-((1S,2S,6R,8S)-8-(2,2-Dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)ethyl)-6-oxo-tetrahydro-2H-pyran-4-yl) 7-((2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoate ;

CAS : 476305-24-5  ; C50H76O10 ; MW: 837.13 ;

Sulfamethazine  RC A :

4-Amino-N-amidinobenzenesulfonamide monohydrate ; CAS : 6190-55-2 ; C7H12N4O3S ; Mol. Wt.: 232.26 ;

Diisopropyl amine :

CAS No: 108-18-9;C6H15N ; MW: 101.19 g/mol;

2-Iodoxybenzoic acid :

 CAS : 61717-82-6 ; C₇H₅IO₄ ; MW: 280.02;

Dess-Martin periodinane :

  1,1,1-Tris(acetyloxy)–1,1-dihydro-1,2-benziodoxol-3-(1H)-one; CAS : 87413-09-0 ;  C13H13IO8   ; MW: 424.14;

Ropivacaine:

  CAS : 84057-95-4 ; C₁₇H₂₆N₂O ; MW: 274.4 ;

Bupivacaine:

  CAS : 38396-39-3 ; C₁₈H₂₈N₂O ; MW: 288.43 ;

Mepivacaine:

  CAS : 96-88-8 ; C₁₅H₂₂N₂O ; MW: 246.348 ;

2-PHENYL-2-ETHYL)-ACETYL-UREA (2-PHENYL-BUTYRIL-UREA :

 CAS : 90-49-3 ; C11H14N2O2 ; MW: 206.24 ;

3-tert-Butyl-p-hydroxyanisole:

  CAS : 121-00-6; C₁₁H₁₆O₂ ; MW: 180.24 ;

Gama Hydroxy Butyric Acid:

 sodium 4-hydroxybutanoate ; CAS : 591-81-1; C4H8O3 ; MW: 126.09;

n(2methylphenyl)2(propylamino)ethanamide.HCl:

n(2methylphenyl)2(propylamino)ethanamide.HCl ; CAS No: 145133-92-2; C12H18N2O.HCl ; MW: 206.28 +36.5 ;

Oleanolic acid:

  CAS : 508-02-1; C₃₀H₄₈O₃; MW: 456.71 ;

1,2,3tricyclohexyl guanidine :

Guanidine,N,N’,N”-tricyclohexy; CAS : 4833-41-4;C19H35 N3; MW: 305.50;

N-(2-ethylamino)-1,2,3,4-tetrahydro-1-naphthamide :

C12H17N ; MW:175.27 ;

N-phenyl-N-benzyl-N’-(2-aminoethyl)-glycinamide.HCl :

C17H21N3O.HCl ; MW:283.37 +36.5;

Phenylacetaldehyde dimethyl acetal :

(2,2-Dimethoxyethyl)benzene; C6H5CH2101-48-4; CH(OCH3)2; MW:166.22 ;

Riboflavin :

 CAS :83-88-5; C₁₇H₂₀N₄O₆; MW: 376.37 ;

SALICYLIC ACID IMPURITY C :

 Phenol ; CAS : 108-95-2 ; C₆H₆O ; MW: 94.11 g/mol ;

19-Norethindrone:

  17α-Ethynyl-17β-hydroxy-19-nor-4-androsten-3-one; CAS : 68-22-4; C20H26O2  ; MW: 298.42 ;

DALFAMPRIDINE METHYLENE BRIDGE IMPURITY:

  N-((pyridin-4-ylamino)methyl)pyridin-4-amine; C11H12N4; MW: 200.24 ;

Methoxy Dibenzazepine :

 10-Methoxy-5H-dibenzo[b,f]azepine ; C15H13NO ; MW:223.28 ;

Folinic acid :

CAS : 1492-18-8; C20H23N7O7 ; MW:473.44  ;

2-Iodoxybenzoic acid :

CAS No : 61717-82-6; C₇H₅IO₄ ; MW: 280.02  ;

2-(4-Isobuytylphenyl) propionic Acid :

CAS NO: 15687-27-1; C13H18O2 ; MW:206.29 ;

Benzenesulfonic Acid Isopropyl Ester :

 Isopropyl Benzenesulfonate;  CAS No: 6214-18-2; C₉H₁₂O₃  ; MW: 200.25;

MYCOPHENOLATE ETHYL ESTER :

(E)-ethyl 6-(1,3-dihydro-7-hydroxy-5-methoxy-4-methyl-1-oxoisobenzofuran-6-yl)-4-methylhex-4-enoate;  CAS No: 128794-94-5;C19H24O6 ; MW: 348.39 ;

Mycophenolic acid sorbitol ester:

(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid sorbitol ester; CAS No:31858-66-9; C23H32O11 ; MW: 484.49 ;

Isopropyl formate :

Isopropyl formate; CAS : 625-55-8; HCO2CH(CH3)2 ; MW: 88.11 ;

4-Hydroxybenzylamine :

CAS :696-60-6; M.F : C₇H₉NO ; MW: 123.15 ;

2 Amino 4 chlorophenol :

 CAS : 95-85-2 ; C₆H₆ClNO ; MW: 143.57;

Febuxostat :

 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic Acid; CAS : 144060-53-7 ; C₁₆H₁₆N₂O₃S  ; MW: 316.38 ;

Metopimazine impurity :

1-[3-(2-methanesulfonyl-10H-phenothiazin-10- yl)propyl]piperidine-4-carboxamide; CAS No: 14008-44-7; C₂₂H₂₇N₃O₃S₂ ; MW: 445.6 g/mol;

Scopolamine :

[7(S)-(1α,2β,4β,5α,7β)]-α-(Hydroxymethyl)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester Benzeneacetic Acid Hydrobromide Trihydrate ; C₁₇H₂₁NO₄ • HBr • ₃(H ₂O) ;  MW:384.27 g/mol      ( 303.3 g/mol ) ;

 Tropic Acid :

(±)-3-Hydroxy-2-phenylpropionic Acid ; C9H10O3 ;  MW:166.18 g/mol   ;

 Docusate Sodium :

 Bis(2-ethylhexyl) Sulfosuccinate Sodium Salt ; C20H37NaO7S ;  MW:444.56 g/mol (421.58 + 22.98 g/mol );

Mesitylene Standard :

1,3,5-Trimethylbenzene ; C9H12 ;  MW: 120.2 g/mol ;

Mesitylene Standard :

1,3,5-Trimethylbenzene ; C9H12 ;  MW: 120.2 g/mol ;